Case number 1:20-cv-01646
Ravgen, Inc. v. Ariosa Diagnostics, Inc. et al. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 25, 2023 | 294 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Responses to Defendants' Third Set of Common Interrogatories (Nos. 17-20) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/25/2023) (4) |
| Sep 25, 2023 | 295 | NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., Roche Molecular Systems, Inc. and Foundation Medicine, Inc.'s First Set of Requests for Admission (Nos. 1-50) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/25/2023) (3) |
| Sep 25, 2023 | 296 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., and Roche Molecular Systems, Inc.'s Second Set of Interrogatories (Nos. 2-5) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/25/2023) (2) |
| Sep 25, 2023 | 297 | NOTICE OF SERVICE of (1) Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc.s Objections and Responses to Plaintiffs First Set of Requests for Admission (Nos. 1-43); Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc.s Objections and Responses to Plaintiffs Second Set of Individual Interrogatories (No. 5); and Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc.s Objections and Responses to Plaintiffs Third Set of Common Interrogatories (Nos. 19-20) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 09/25/2023) (2) |
| Sep 22, 2023 | 292 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Supplemental Responses to Defendants' First Set of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/22/2023) (4) |
| Sep 22, 2023 | 293 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendants' Third Set of Requests for Production of Documents and Things (Nos. 144-150) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/22/2023) (3) |
| Sep 19, 2023 | 291 | MOTION for Pro Hac Vice Appearance of Attorney Gillian F. Moore and Kevin Goon - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Michael) (Entered: 09/19/2023) (4) |
| Sep 15, 2023 | 290 | NOTICE OF SERVICE of Objections and Responses to Plaintiff's Second Set of Common Interrogatories (Nos. 16-18) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 09/15/2023) (2) |
| Sep 14, 2023 | 289 | MOTION for Pro Hac Vice Appearance of Attorney James M. Dowd - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. Motions referred to Jennifer L. Hall.(Haynes, Christine) (Entered: 09/14/2023) (3) |
| Sep 13, 2023 | 288 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Amended Privilege Log filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/13/2023) (3) |
| Sep 8, 2023 | 285 | ORAL ORDER: Defendants' Motion to Set an Early Inequitable Conduct Trial (C.A. No. 20-1646, D.I. 234; C.A. No. 20-1730, D.I. 157; C.A. No. 20-1734, D.I. 167) is DENIED. The Court is not persuaded under the circumstances that holding an inequitable conduct bench trial a year before the scheduled jury trial is the most efficient way to proceed with these cases. Ordered by Judge Jennifer L. Hall on 9/8/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 09/08/2023) (0) |
| Sep 8, 2023 | 286 | STIPULATION Extending Case Schedule, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) (Entered: 09/08/2023) (4) |
| Sep 8, 2023 | 287 | NOTICE OF SERVICE of 1) First Supplemental Objections and Responses to Plaintiffs First Set of Common Interrogatories (Nos. 1-15) and 2) First Supplemental Objections and Responses to Plaintiffs First Set of Individual Interrogatories (Nos. 1-4) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 09/08/2023) (2) |
| Sep 7, 2023 | 283 | NOTICE to Take Deposition of Anna Capovilla on 9/27/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/07/2023) (2) |
| Sep 7, 2023 | 284 | NOTICE to Take Deposition of Reza Savari on 10/5/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/07/2023) (2) |
| Sep 5, 2023 | 281 | REDACTED VERSION of 279 Reply Brief, by Biora Therapeutics, Inc.. (Joyce, Alexandra) Modified on 9/5/2023 (nms). (Entered: 09/05/2023) (30) |
| Sep 5, 2023 | 282 | NOTICE OF SERVICE of Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc.'s Second Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 09/05/2023) (2) |
| Aug 31, 2023 | 280 | NOTICE to Take Deposition of Leah Ledesma on 10/4/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/31/2023) (2) |
| Aug 28, 2023 | 279 | [SEALED] REPLY BRIEF re 234 MOTION to Set an Inequitable Conduct Trial filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 Exhibit 1-4)(Haynes, Christine) (Attachment 1 replaced on 8/29/2023) (lah). (Entered: 08/28/2023) (0) |
| Aug 23, 2023 | 272 | Letter to The Honorable Jennifer L. Hall, from Christine D. Haynes, regarding pre-trial and trial severance status update. (Haynes, Christine) Modified on 8/23/2023 (nms). (Entered: 08/23/2023) (2) |
| Aug 23, 2023 | 273 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Third Set of Common Interrogatories to Defendants (Nos. 19-20) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/23/2023) (4) |
| Aug 23, 2023 | 274 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Set of Requests for Admission (Authentication) to Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., and Roche Molecular Systems, Inc. (Nos. 44246) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/23/2023) (3) |
| Aug 23, 2023 | 275 | NOTICE OF SERVICE of Defendant Foundation Medicine, Inc.'s First Set of Individual Interrogatoriesto Plaintiff Ravgen, Inc. (Nos. 1-5) filed by Foundation Medicine, Inc..(Haynes, Christine) (Entered: 08/23/2023) (2) |
| Aug 23, 2023 | 276 | NOTICE OF SERVICE of Defendants' Third Set of Common Interrogatories to Plaintiff Ravgen, Inc. (Nos. 17-20) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 08/23/2023) (3) |
| Aug 23, 2023 | 277 | NOTICE OF SERVICE of Defendant Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc.s Third Set of Requests for Production of Documents and Things from Plaintiff (Nos. 144-150) and Second Set of Individual Interrogatories to Plaintiff Ravgen, Inc. (Nos. 2-5) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 08/23/2023) (2) |
| Aug 23, 2023 | 278 | NOTICE OF SERVICE of Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., Roche Molecular Systems, Inc. and Foundation Medicine, Inc.s First Set of Requests for Admission to Plaintiff Ravgen, Inc. and First Set of Requests for Authentication to Plaintiff Ravgen, Inc. filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 08/23/2023) (3) |
| Aug 22, 2023 | 271 | NOTICE OF SERVICE of (i) Plaintiff Ravgen, Inc.'s First Set of Requests for Admission to Foundation Medicine, Inc. (Nos. 1-7); (ii) Plaintiff Ravgen, Inc.'s First Set of Requests for Admission to Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., and Roche Molecular Systems, Inc. (Nos. 1-43); and (iii) Plaintiff Ravgen, Inc.'s Second Set of Individual Interrogatories to Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., and Roche Molecular Systems, Inc. (No. 5) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/22/2023) (3) |
| Aug 21, 2023 | 270 | NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Farnan, Brian) (Entered: 08/21/2023) (0) |
| Aug 18, 2023 | 269 | ORAL ORDER: Having reviewed the parties' letters (C.A. No. 20-1646, D.I. 262, 266; C.A. No. 20-1730, D.I. 189, 192; C.A. No. 20-1734, D.I. 185, 187), the Court is not convinced that it is appropriate to order case narrowing prior to the issuance of the claim construction order. Accordingly, IT IS HEREBY ORDERED that the discovery motion (C.A. No. 20-1646, D.I. 241; C.A. No. 20-1730, D.I. 171; C.A. No. 20-1734, D.I. 170) is DENIED without prejudice to re-raise after issuance of the claim construction order. The parties must meet and confer prior to a subsequent discovery motion raising this issue. The parties are encouraged to continue working towards narrowing the case in the interim. Accordingly, the teleconference scheduled for August 18, 2023 at 3:00 pm is CANCELLED. Ordered by Judge Jennifer L. Hall on 8/18/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 08/18/2023) (0) |
| Aug 17, 2023 | 268 | STIPULATION and Proposed Order to Extend Time to file a Reply Brief in Support of Motion to Set an Inequitable Conduct Trial to August 28, 2023 - filed by Biora Therapeutics, Inc.. (Joyce, Alexandra) Modified on 8/18/2023 (nms). (Entered: 08/17/2023) (2) |
| Aug 16, 2023 | 264 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Set of Common Interrogatories to Defendants (Nos. 16-18) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/16/2023) (4) |
| Aug 16, 2023 | 265 | NOTICE OF SERVICE of Plaintiff's First Set of Individual Requests for Production of Documents and Things to Foundation Medicine, Inc. (Nos. 87-89) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/16/2023) (3) |
| Aug 16, 2023 | 266 | Letter to The Honorable Jennifer L. Hall, from Michael J. Farnan, regarding response to Defendants' August 14, 2023, letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Michael) Modified on 8/16/2023 (nms). (Entered: 08/16/2023) (0) |
| Aug 16, 2023 | 267 | NOTICE of Subpoena by Ravgen, Inc. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 08/16/2023) (0) |
| Aug 15, 2023 | 263 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Set of Individual Interrogatories to Foundation Medicine, Inc. (Nos. 1-3) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/15/2023) (3) |
| Aug 14, 2023 | 259 | ANSWERING BRIEF in Opposition re 234 MOTION to Set an Inequitable Conduct Trial filed by Ravgen, Inc..Reply Brief due date per Local Rules is 8/21/2023. (Farnan, Brian) (Entered: 08/14/2023) (18) |
| Aug 14, 2023 | 260 | DECLARATION of Julianne Thomsen re 259 Answering Brief in Opposition by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6) (Farnan, Brian) Modified on 8/14/2023 (ceg). Modified on 8/15/2023 (nms). (Entered: 08/14/2023) (0) |
| Aug 14, 2023 | 261 | RESPONSE to 235 Objections, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) Modified on 8/15/2023 (nms). (Entered: 08/14/2023) (11) |
| Aug 14, 2023 | 262 | Letter to The Honorable Jennifer L. Hall, from Daniel M. Silver, regarding discovery dispute on claim narrowing. (Attachments: # 1 Proposed Order, # 2 Exhibits 1-5)(Silver, Daniel) Modified on 8/15/2023 (nms). (Entered: 08/14/2023) (0) |
| Aug 11, 2023 | 256 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Responses to Defendants' Second Set of Common Interrogatories (Nos. 15-16) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/11/2023) (4) |
| Aug 11, 2023 | 257 | NOTICE to Take Deposition of Ryan Woodhouse on September 8, 2023 filed by Ravgen, Inc..(Farnan, Michael) (Entered: 08/11/2023) (2) |
| Aug 11, 2023 | 258 | NOTICE to Take Deposition of Sergio Alvarez on September 11, 2023 filed by Ravgen, Inc..(Farnan, Michael) (Entered: 08/11/2023) (2) |
| Aug 10, 2023 | 255 | NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Farnan, Brian) (Entered: 08/10/2023) (0) |
| Aug 9, 2023 | 254 | NOTICE of Subpoena to Deborah S. Kipp by Ravgen, Inc. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 08/09/2023) (0) |
| Aug 8, 2023 | 252 | NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Farnan, Brian) (Entered: 08/08/2023) (0) |
| Aug 8, 2023 | 253 | MOTION for Pro Hac Vice Appearance of Attorney Jennifer Przybylski - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Brian) (Entered: 08/08/2023) (3) |
| Aug 7, 2023 | 251 | RESPONSE to 212 Objections, by Ravgen, Inc.. (Farnan, Brian) Modified on 8/8/2023 (nms). (Entered: 08/07/2023) (14) |
| Aug 4, 2023 | 240 | NOTICE to Take Deposition of Joy Berberich on 8/21/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 241 | MOTION for Teleconference to Resolve Discovery Dispute - filed by Biora Therapeutics, Inc.. Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 08/04/2023) (3) |
| Aug 4, 2023 | 242 | NOTICE to Take Deposition of Lucas Dennis on 9/6/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 243 | NOTICE to Take Deposition of Julie Hersh on 8/23/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 244 | NOTICE to Take Deposition of Christine Malboeuf on 8/22/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 245 | NOTICE to Take Deposition of Elizabeth Mansfield on 9/8/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 246 | NOTICE to Take Deposition of Annie Murphy on 8/29/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 247 | NOTICE to Take Deposition of John Scola on 9/7/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 248 | NOTICE to Take Deposition of Renee Stokowski on 8/30/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 249 | NOTICE to Take Deposition of Brett Wallden on 8/28/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023) (2) |
| Aug 4, 2023 | 250 | ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Disputes (C.A. No. 20-1646, D.I. 241; C.A. No. 20-1730, D.I. 171; C.A. No. 20-1734, D.I. 170). A discovery dispute teleconference is scheduled for August 18, 2023 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than August 14, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than August 16, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. The letter shall address all outstanding discovery disputes. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 8/4/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 08/04/2023) (0) |
| Aug 3, 2023 | 237 | NOTICE OF SERVICE of Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc. Objections and Responses to Plaintiff's First Set of Individual Interrogatories (Nos. 1-4) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 08/03/2023) (2) |
| Aug 3, 2023 | 238 | NOTICE OF SERVICE of 1) Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1)(A) and (2); and 2) Supplemental Disclosures Pursuant to Paragraph 3 of Court's Default Standard for Discovery filed by Foundation Medicine, Inc..(Haynes, Christine) (Entered: 08/03/2023) (2) |
| Aug 3, 2023 | 239 | NOTICE of Subpoena to Sarah Emche by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 08/03/2023) (0) |
| Aug 2, 2023 | 236 | NOTICE OF SERVICE of Objections and Responses of Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc. Under Fed. R. Civ. P. 30(b)(6) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 08/02/2023) (2) |
| Jul 31, 2023 | 234 | MOTION to Set an Inequitable Conduct Trial - filed by Biora Therapeutics, Inc.. (Attachments: # 17.1.1 Certification, # 2 Proposed Order, # 3 Exhibits 1-31)Motions referred to Jennifer L. Hall.(Joyce, Alexandra) Modified on 8/1/2023 (nms). (Entered: 07/31/2023) (0) |
| Jul 31, 2023 | 235 | OBJECTION to 205 Report and Recommendations, by Ravgen, Inc.. (Attachments: # 1 Certification)(Farnan, Brian) Modified on 8/1/2023 (nms). (Entered: 07/31/2023) (0) |
| Jul 28, 2023 | 232 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Privilege Log filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/28/2023) (3) |
| Jul 28, 2023 | 233 | NOTICE OF SERVICE of Privilege Log filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 07/28/2023) (2) |
| Jul 27, 2023 | 226 | NOTICE of Subpoena on Becton, Dickinson and Company by Foundation Medicine, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Attachment 1 replaced on 7/27/2023) (ceg). (Entered: 07/27/2023) (0) |
| Jul 27, 2023 | 227 | NOTICE of Subpoena to be served on PreAnalytiX GmbH, c/o Becton, Dickinson and Company by Foundation Medicine, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 07/27/2023) (0) |
| Jul 27, 2023 | 228 | NOTICE of Subpoena to be served on PreAnalytiX GmbH, c/o Qiagen North American Holdings, Inc. by Foundation Medicine, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 07/27/2023) (0) |
| Jul 27, 2023 | 229 | NOTICE of Subpoena to be served on Qiagen, LLC by Foundation Medicine, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 07/27/2023) (0) |
| Jul 27, 2023 | 230 | NOTICE of Subpoena to be served on Qiagen North American Holdings, Inc. by Foundation Medicine, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 07/27/2023) (0) |
| Jul 27, 2023 | 231 | NOTICE of Subpoena to be served on Qiagen Sciences, Inc. by Foundation Medicine, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 07/27/2023) (0) |
| Jul 26, 2023 | 225 | NOTICE OF SERVICE of Responses and Objections to Ravgens First Notice of Deposition Pursuant to Rule 30(b)(6) filed by Foundation Medicine, Inc..(Haynes, Christine) (Entered: 07/26/2023) (2) |
| Jul 24, 2023 | 223 | REDACTED VERSION of 214 Notice (Other) by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 07/24/2023) (0) |
| Jul 24, 2023 | 224 | NOTICE of Subpoena to Menarini Silicon Biosystems, Inc. by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 07/24/2023) (0) |
| Jul 21, 2023 | 221 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Ariosa Diagnostics, Inc.'s, Roche Sequencing Solutions, Inc.'s, and Roche Molecular Systems, Inc.'s First Set of Interrogatories to Plaintiff (No. 1) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/21/2023) (3) |
| Jul 21, 2023 | 222 | NOTICE OF SERVICE of First Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 07/21/2023) (2) |
| Jul 19, 2023 | 218 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Supplemental Responses to Defendants' First Set of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/19/2023) (3) |
| Jul 19, 2023 | 219 | STIPULATION Extending the deadlines for: (i) Plaintiff to file its objections to the Report and Recommendation and (ii) Plaintiff to respond to Defendants' Objection to (i) 7/31/2023 and (ii) 8/7/2023 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/19/2023) (3) |
| Jul 19, 2023 | 220 | JOINT Interim Status Report, by Ravgen, Inc.. (Farnan, Brian) Modified on 7/19/2023 (nms). (Entered: 07/19/2023) (4) |
| Jul 18, 2023 | 217 | NOTICE OF SERVICE of Defendant Foundation Medicine, Inc.'s Objections and Responses to First Set of Common Interrogatories to Defendants (Nos. 1-15) filed by Foundation Medicine, Inc..(Haynes, Christine) (Entered: 07/18/2023) (2) |
| Jul 17, 2023 | 216 | NOTICE OF SERVICE of (1) Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc.'s Response to Plaintiff's Third Set of Requests for Production of Documents and Things (Nos. 77- 86) and (2) Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc.'s Objections and Responses to Plaintiff's First Set of Common Interrogatories (Nos. 1-15) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 07/17/2023) (2) |
| Jul 13, 2023 | 213 | NOTICE of Subpoena to Frank J. Garofalo by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 07/13/2023) (0) |
| Jul 13, 2023 | 214 | [SEALED] NOTICE of Subpoena by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 07/13/2023) (0) |
| Jul 13, 2023 | 215 | MOTION for Pro Hac Vice Appearance of Attorney Charles T. Cox - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. Motions referred to Jennifer L. Hall.(Haynes, Christine) (Entered: 07/13/2023) (3) |
| Jul 12, 2023 | 207 | STIPULATION Extending Deadline to submit the Joint Interim Status Report to 7/19/2023 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/12/2023) (2) |
| Jul 12, 2023 | 208 | REDACTED VERSION of 202 Notice to Take Deposition by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 07/12/2023) (0) |
| Jul 12, 2023 | 209 | REDACTED VERSION of 203 Notice to Take Deposition by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 07/12/2023) (0) |
| Jul 12, 2023 | 210 | REDACTED VERSION of 204 Notice to Take Deposition by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 07/12/2023) (0) |
| Jul 12, 2023 | 211 | NOTICE OF SERVICE of Defendants' Second Set of Common Interrogatories to Plaintiff Ravgen, Inc. (Nos. 15-16) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 07/12/2023) (3) |
| Jul 12, 2023 | 212 | OBJECTIONS to 205 Report and Recommendaiton, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 Certification, # 2 Exhibits A-B)(Haynes, Christine) Modified on 7/12/2023 (nms). (Entered: 07/12/2023) (0) |
| Jul 11, 2023 | 206 | STIPULATION Extending the deadline for privilege logs to 7/28/2023 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/11/2023) (1) |
| Jul 10, 2023 | 205 | REPORT AND RECOMMENDATION re Claim Construction Disputes. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 7/24/2023. Signed by Judge Jennifer L. Hall on 7/10/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 07/10/2023) (16) |
| Jul 5, 2023 | 200 | NOTICE OF SERVICE of Plaintiff Ravgen's Objections and Responses to Defendants Ariosa Diagnostics, Inc.'s, Roche Sequencing Solutions, Inc.'s, Roche Molecular Systems, Inc.'s, and Foundation Medicine, Inc.'s Notice of Deposition to Ravgen, Inc. filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/05/2023) (3) |
| Jul 5, 2023 | 201 | NOTICE to Take Deposition of Foundation Medicine, Inc. on August 2, 2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/05/2023) (17) |
| Jul 5, 2023 | 202 | [SEALED] NOTICE to Take Deposition of Ariosa Diagnostics, Inc. on August 7, 2023 filed by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 07/05/2023) (0) |
| Jul 5, 2023 | 203 | [SEALED] NOTICE to Take Deposition of Roche Molecular Systems, Inc. on August 7, 2023 filed by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 07/05/2023) (0) |
| Jul 5, 2023 | 204 | [SEALED] NOTICE to Take Deposition of Roche Sequencing Solutions, Inc. on August 7, 2023 filed by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 07/05/2023) (0) |
| Jul 3, 2023 | 199 | NOTICE OF SERVICE of Foundation Medicine, Inc.'s Objections & Responses to Ravgen, Inc.'s Third Set of Requests for the Production of Documents and Things (Nos. 77-86) filed by Foundation Medicine, Inc..(Haynes, Christine) (Entered: 07/03/2023) (2) |
| Jun 30, 2023 | 191 | REDACTED VERSION of 189 Notice to Take Deposition of Ravgen, Inc., by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) Modified on 6/30/2023 (nms). (Entered: 06/30/2023) (21) |
| Jun 30, 2023 | 192 | NOTICE to Take Deposition of Dr. Ravinder Dhallan on August 14, 2023 filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 06/30/2023) (2) |
| Jun 30, 2023 | 193 | NOTICE to Take Deposition of John Varney on September 6, 2023 filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 06/30/2023) (2) |
| Jun 30, 2023 | 194 | NOTICE to Take Deposition of Dr. Xin Guo on September 19, 2023 filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 06/30/2023) (2) |
| Jun 30, 2023 | 195 | NOTICE of Subpoena to Subhendra Mattagajasingh by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 06/30/2023) (0) |
| Jun 30, 2023 | 196 | NOTICE of Subpoena to Wei-Chun Au by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 06/30/2023) (0) |
| Jun 30, 2023 | 197 | NOTICE of Subpoena to Marian Damewood by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 06/30/2023) (0) |
| Jun 30, 2023 | 198 | NOTICE of Subpoena to Alicia Hager by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Entered: 06/30/2023) (0) |
| Jun 27, 2023 | 190 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Set of Individual Interrogatories to Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., and Roche Molecular Systems, Inc. (Nos. 1-4) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 06/27/2023) (2) |
| Jun 22, 2023 | 188 | NOTICE OF SERVICE of First Set of Interrogatories to Plaintiff Ravgen, Inc. (No. 1) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 06/22/2023) (2) |
| Jun 22, 2023 | 189 | [SEALED] NOTICE to Take Deposition of Ravgen, Inc. on July 13, 2023 filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 06/22/2023) (0) |
| Jun 21, 2023 | 186 | Letter to The Honorable Richard G. Andrews, from Brian E. Farnan, regarding proposed claim construction order. (Attachments: # 1 Exhibit 1)(Farnan, Brian) Modified on 6/21/2023 (nms). (Entered: 06/21/2023) (0) |
| Jun 21, 2023 | 187 | CLAIM CONSTRUCTION ORDER CONSTRUING AGREED TERMS (see Order for further details). Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(nms) (Entered: 06/21/2023) (2) |
| Jun 15, 2023 | 184 | NOTICE of Subpoena to Husch Blackwell LLP by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Attachment 1 replaced on 6/16/2023) (ceg). (Entered: 06/15/2023) (0) |
| Jun 15, 2023 | 185 | NOTICE of Subpoena to Michael J. Cronin by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Haynes, Christine) (Attachment 1 replaced on 6/16/2023) (ceg). (Entered: 06/15/2023) (0) |
| Jun 13, 2023 | 183 | NOTICE OF SERVICE of Defendants' Second Amended Invalidity Contentions filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 06/13/2023) (2) |
| Jun 12, 2023 | 182 | NOTICE OF SERVICE of First Amended ESI Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 06/12/2023) (2) |
| Jun 5, 2023 | 180 | NOTICE OF SERVICE of Plaintiff's Third Set of Requests for the Production of Documents and Things (Nos. 77-86) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 06/05/2023) (3) |
| Jun 5, 2023 | 181 | NOTICE OF SERVICE of Plaintiff Ravgen's First Responses To Defendants' First Set Of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Michael) (Entered: 06/05/2023) (4) |
| Jun 2, 2023 | 179 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Set of Common Interrogatories to Defendants (Nos. 1-15) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 06/02/2023) (4) |
| May 31, 2023 | 178 | ORAL ORDER Setting Teleconference: A teleconference is scheduled for June 1, 2023 at 4:00 PM before Judge Jennifer L. Hall, at which time the Court anticipates issuing its Report and Recommendation on the pending claim construction disputes. Counsel shall send dial-in information directly to the Court using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. Ordered by Judge Jennifer L. Hall on 5/31/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/31/2023) (0) |
| May 30, 2023 | 177 | ORDER granting Joint Motion for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices (C.A. 20-1646, D.I. 175; C.A. No. 20-1730, D.I. 122; C.A. No. 20-1734, D.I. 133). Signed by Judge Jennifer L. Hall on 5/30/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Main Document 177 replaced on 5/30/2023) (ceg). (Entered: 05/30/2023) (2) |
| May 28, 2023 | 176 | Letter to The Honorable Jennifer L. Hall, from Jeremy A. Tigan, regarding agreed-upon construction of "Mutation" in advance of the Markman hearing. (Tigan, Jeremy) Modified on 5/30/2023 (nms). (Entered: 05/28/2023) (2) |
| May 26, 2023 | 175 | MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Biora Therapeutics, Inc.. (Attachments: # 1 Proposed Order)Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 05/26/2023) (0) |
| May 24, 2023 | 174 | Letter to The Honorable Jennifer L. Hall, from Brian E. Farnan, regarding deposition limitations. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Farnan, Brian) Modified on 5/25/2023 (nms). (Entered: 05/24/2023) (0) |
| May 19, 2023 | 172 | STIPULATION TO EXTEND TIME for the Joint Status Report on Deposition Limitations to 5/24/2023 - filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/19/2023) (2) |
| May 19, 2023 | 173 | NOTICE OF SERVICE of Non-Party WellSpan York Hospital's Objections and Responses to Defendants Ariosa Diagnostics, Inc., Roche Sequencing Sols., Inc. and Roche Molecular Sys., Inc.'s Subpoena For Documents re 136 Notice (Other), filed by WellSpan York Hospital.(Scrivani, Stacey) (Entered: 05/19/2023) (1) |
| May 18, 2023 | 171 | ORAL ORDER: The Markman hearing scheduled for May 31, 2023 at 10:00 AM before Judge Hall will be conducted in-person in courtroom TBD. Each side shall be allocated 90 minutes for its presentation (i.e., the total allocation of time for the hearing will be 3 hours). Any slide presentations or demonstratives that the parties wish to use during the hearing shall be emailed to Cailah_Garfinkel@ded.uscourts.gov no later than 24 hours prior to the hearing. Ordered by Judge Jennifer L. Hall on 5/18/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/18/2023) (0) |
| May 17, 2023 | 170 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendant Foundation Medicine, Inc.'s Second Set of Requests for Production of Documents and Things (Nos. 102-122) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 05/17/2023) (2) |
| May 16, 2023 | 169 | NOTICE of Subsequent Authority Regarding Claim Construction by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Farnan, Brian) (Entered: 05/16/2023) (0) |
| May 5, 2023 | 167 | NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Farnan, Brian) (Entered: 05/05/2023) (0) |
| May 5, 2023 | 168 | NOTICE OF SERVICE of Defendants' First Set of Common Interrogatories (Nos. 1-14) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 05/05/2023) (2) |
| May 4, 2023 | 165 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holdings, Inc. for Foundation Medicine, Inc. filed by Foundation Medicine, Inc.. (Haynes, Christine) (Entered: 05/04/2023) (2) |
| May 4, 2023 | 166 | NOTICE OF SERVICE of Defendant Foundation Medicine, Inc.'s (1) Supplemental Disclosures Pursuant to Paragraph 3 of the Courts Default Standard for Discovery, and (2) Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1)(A) filed by Foundation Medicine, Inc..(Haynes, Christine) (Entered: 05/04/2023) (2) |
| Apr 28, 2023 | 164 | NOTICE OF SERVICE of Ravgen's Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Ravgen, Inc..(Farnan, Brian) (Entered: 04/28/2023) (3) |
| Apr 21, 2023 | 163 | MOTION for Pro Hac Vice Appearance of Attorney Frederick J. Ding, Julianne M. Thomsen, and William B. Nichols - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Michael) (Entered: 04/21/2023) (5) |
| Apr 17, 2023 | 158 | REDACTED VERSION of 154 Appendix, Volume 4 of 4, by Ravgen, Inc.. (Attachments: # 1 Exhibit D27, # 2 Exhibit D28, # 3 Exhibit D29, # 4 Exhibit D30, # 5 Exhibit D31, # 6 Exhibit D32, # 7 Exhibit D33, # 8 Exhibit D34, # 9 Exhibit D35, # 10 Exhibit D36, # 11 Exhibit D37, # 12 Exhibit D38, # 13 Exhibit D39, # 14 Exhibit D40, # 15 Exhibit D41, # 16 Exhibit D42, # 17 Exhibit D43, # 18 Exhibit D44, # 19 Exhibit D45, # 20 Exhibit D46, # 21 Exhibit D47, # 22 Exhibit D48, # 23 Exhibit D49, # 24 Exhibit D50, # 25 Exhibit D51, # 26 Exhibit D52, # 27 Exhibit D53, # 28 Exhibit D54, # 29 Exhibit D55, # 30 Exhibit D56, # 31 Exhibit D57, # 32 Exhibit D58, # 33 Exhibit D59, # 34 Exhibit D60, # 35 Certificate of Service)(Farnan, Michael) Modified on 4/17/2023 (nms). (Entered: 04/17/2023) (0) |
| Apr 17, 2023 | 159 | NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendants Ariosa Diagnostics, Inc.'s, Roche Sequencing Solutions, Inc.'s, and Roche Molecular Systems, Inc.'s Second Set of Requests for Production of Documents and Things (Nos. 123-143) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 04/17/2023) (3) |
| Apr 17, 2023 | 160 | NOTICE OF SERVICE of Roche Defendants' Response to Plaintiff's Requests for the Production of Documents and Things (Nos. 73-76) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 04/17/2023) (2) |
| Apr 17, 2023 | 161 | NOTICE OF SERVICE of Foundation Medicine, Inc.'s Second Set of Requests for Production to Plaintiff Ravgen, Inc. (Nos. 102-122) filed by Foundation Medicine, Inc..(Haynes, Christine) (Entered: 04/17/2023) (2) |
| Apr 17, 2023 | 162 | NOTICE OF SERVICE of Foundation Medicine, Inc.'s Objections and Responses to Ravgen's Second Set of Requests for the Production of Documents and Things (Nos. 73-76) filed by Foundation Medicine, Inc..(Haynes, Christine) (Entered: 04/17/2023) (2) |
| Apr 13, 2023 | 156 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Molecular Systems, Inc. for Roche Sequencing Solutions, Inc.; Corporate Parent BioReference Laboratories, Inc. for Ariosa Diagnostics, Inc.; Corporate Parent Roche Holdings Inc. for Roche Molecular System, Inc. filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) (Entered: 04/13/2023) (2) |
| Apr 13, 2023 | 157 | REDACTED VERSION of 145 Exhibit to a Document by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) (Entered: 04/13/2023) (20) |
| Apr 10, 2023 | 148 | NOTICE of filing the following Non-Paper material(s) in multi media format: Plaintiff's Technology Tutorial. Original Non-paper material(s) to be filed with the Clerk's Office. Notice filed by Brian E. Farnan on behalf of Ravgen, Inc. (Farnan, Brian) (Entered: 04/10/2023) (3) |
| Apr 10, 2023 | 149 | NOTICE of Lodging Defendants' Technology Tutorial with the Court by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Haynes, Christine) (Entered: 04/10/2023) (2) |
| Apr 10, 2023 | 150 | JOINT Claim Construction Brief, filed by Ravgen, Inc.. (Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (30) |
| Apr 10, 2023 | 151 | APPENDIX, Volume 1 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (0) |
| Apr 10, 2023 | 152 | APPENDIX, Volume 2 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit P30, # 2 Exhibit P31, # 3 Exhibit P32, # 4 Exhibit P33, # 5 Exhibit P34, # 6 Exhibit P35, # 7 Exhibit P36, # 8 Exhibit P37, # 9 Exhibit P38, # 10 Exhibit P39, # 11 Exhibit P40, # 12 Exhibit P41, # 13 Exhibit P42, # 14 Exhibit P43, # 15 Exhibit P44, # 16 Exhibit P45, # 17 Exhibit P46, # 18 Exhibit P47, # 19 Exhibit P48, # 20 Exhibit P49, # 21 Exhibit P50, # 22 Exhibit P51, # 23 Exhibit P52, # 24 Exhibit P53, # 25 Exhibit P54, # 26 Exhibit P55, # 27 Exhibit P56, # 28 Exhibit P57, # 29 Exhibit P58)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (0) |
| Apr 10, 2023 | 153 | APPENDIX, Volume 3 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit D1, # 2 Exhibit D2, # 3 Exhibit D3, # 4 Exhibit D4, # 5 Exhibit D5, # 6 Exhibit D6, # 7 Exhibit D7, # 8 Exhibit D8, # 9 Exhibit D9, # 10 Exhibit D10, # 11 Exhibit D11, # 12 Exhibit D12, # 13 Exhibit D13, # 14 Exhibit D14, # 15 Exhibit D15, # 16 Exhibit D16, # 17 Exhibit D17, # 18 Exhibit D18, # 19 Exhibit D19, # 20 Exhibit D20, # 21 Exhibit D21, # 22 Exhibit D22, # 23 Exhibit D23, # 24 Exhibit D24, # 25 Exhibit D25, # 26 Exhibit D26)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (0) |
| Apr 10, 2023 | 154 | [SEALED] APPENDIX, Volume 4 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit D27, # 2 Exhibit D28, # 3 Exhibit D29, # 4 Exhibit D30, # 5 Exhibit D31, # 6 Exhibit D32, # 7 Exhibit D33, # 8 Exhibit D34, # 9 Exhibit D35, # 10 Exhibit D36, # 11 Exhibit D37, # 12 Exhibit D38, # 13 Exhibit D39, # 14 Exhibit D40, # 15 Exhibit D41, # 16 Exhibit D42, # 17 Exhibit D43, # 18 Exhibit D44, # 19 Exhibit D45, # 20 Exhibit D46, # 21 Exhibit D47, # 22 Exhibit D48, # 23 Exhibit D49, # 24 Exhibit D50, # 25 Exhibit D51, # 26 Exhibit D52, # 27 Exhibit D53, # 28 Exhibit D54, # 29 Exhibit D55, # 30 Exhibit D56, # 31 Exhibit D57, # 32 Exhibit D58, # 33 Exhibit D59, # 34 Exhibit D60, # 35 Certificate of Service)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (0) |
| Apr 10, 2023 | 155 | Letter to The Honorable Jennifer L. Hall, from Michael J. Farnan, regarding Markman hearing. (Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023) (1) |
| Apr 5, 2023 | 147 | AMENDED ANSWER to 33 Amended Complaint, by Foundation Medicine, Inc.. (Attachments: # 1 Exhibits 1-5, # 2 Exhibits 6-10, # 3 Exhibits 11-17, # 4 Exhibits 18-21)(Cottrell, Frederick) Modified on 4/5/2023 (nms). (Entered: 04/05/2023) (0) |
| Apr 4, 2023 | 146 | NOTICE OF SERVICE of 1) Defendants' Sur-Reply Construction Brief; 2) Declaration of R. Noyes in Support of Defendants' Sur-Reply Claim Construction Brief; and 3) Declaration of Michael L. Metzker in Support of Defendants' Sur-Reply Claim Construction Brief filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 04/04/2023) (2) |
| Apr 3, 2023 | 143 | AMENDED ANSWER to 33 Amended Complaint by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 2-9) (Cottrell, Frederick) Modified on 4/3/2023 (ceg). (Entered: 04/03/2023) (0) |
| Apr 3, 2023 | 144 | EXHIBIT 10-25 re 143 Amended Answer to Complaint by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Cottrell, Frederick) Modified on 4/3/2023 (ceg). (Entered: 04/03/2023) (30) |
| Apr 3, 2023 | 145 | [SEALED] EXHIBIT 1 re 143 Amended Answer to Complaint by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Cottrell, Frederick) Modified on 4/3/2023 (ceg). (Entered: 04/03/2023) (0) |
| Mar 30, 2023 | 142 | NOTICE OF SERVICE of Defendants' First Amended Invalidity Contentions filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 03/30/2023) (2) |
| Mar 29, 2023 | 141 | ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the March 29, 2023 discovery dispute teleconference shall serve as the Order of the Court. Ordered by Judge Jennifer L. Hall on 3/29/2023. Associated Cases: 1:20-cv-01734-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH(ceg) (Entered: 03/29/2023) (0) |
| Mar 28, 2023 | 140 | AMENDED SCHEDULING ORDER: Claim Construction Surreply Brief due by 4/3/2023. Joint Claim Construction Brief and Technology Tutorials due by 4/10/2023. A Markman Hearing is set for 5/31/2023 at 10:00 AM before Judge Jennifer L. Hall. Interim Status Report due by 7/15/2023. Joinder of Parties due by 7/26/2023. Amended Pleadings due by 7/26/2023. Fact Discovery completed by 9/22/2023. Expert Discovery due by 2/16/2024. Case Dispositive Motions due by 4/4/2024. Answering Brief due 5/2/2024. Reply Brief due 5/16/2024. A Motion Hearing is set for 6/13/2024 at 01:00 PM before Judge Jennifer L. Hall. A Trial Sequencing Conference is set for 4/22/2024 at 01:00 PM before Judge Jennifer L. Hall. Proposed Pretrial Order due by 10/14/2024. A Pretrial Conference is set for 10/18/2024 at 09:00 AM in Courtroom 6A before Judge Richard G. Andrews. A 5-day Jury Trial is set for 10/28/2024 at 09:30 AM in Courtroom 6A before Judge Richard G. Andrews. (*See Order for details). Signed by Judge Jennifer L. Hall on 3/28/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/28/2023) (15) |
| Mar 24, 2023 | 139 | PROPOSED Amended Scheduling Order, by Ravgen, Inc.. (Attachments: # 1 Letter)(Farnan, Michael) Modified on 3/24/2023 (nms). (Entered: 03/24/2023) (0) |
| Mar 23, 2023 | 138 | REDACTED VERSION of 137 Letter, by Ravgen, Inc.. (Attachments: # 1 Exhibits A-C)(Farnan, Brian) Modified on 3/23/2023 (nms). (Entered: 03/23/2023) (0) |
| Mar 22, 2023 | 137 | [SEALED] Letter to The Honorable Jennifer L. Hall, from Brian E. Farnan, regarding response to Defendants' March 16, 2023 letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Farnan, Brian) Modified on 3/22/2023 (nms). (Entered: 03/22/2023) (0) |
| Mar 17, 2023 | 132 | NOTICE OF SERVICE of Plaintiff's Second Set of Requests for the Production of Documents and Things (Nos. 73-76) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 03/17/2023) (3) |
| Mar 17, 2023 | 133 | NOTICE OF SERVICE of Ariosa Diagnostics, Inc.'s, Roche Sequencing Solutions, Inc.'s, and Roche Molecular Systems, Inc.'s Second Set of Requests for Production of Documents and Things from Plaintiff (Nos. 123-143) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Cottrell, Frederick) (Entered: 03/17/2023) (2) |
| Mar 17, 2023 | 134 | NOTICE of Subpoena to Produce Documents, Information, or Objects or to Permit for Inspection, for Dr. Philip Bayliss by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Cottrell, Frederick) (Entered: 03/17/2023) (0) |
| Mar 17, 2023 | 135 | NOTICE of Subpoena to Produce Documents, Information, or Objects or to Permit for Inspection, for Dr. Kimberly Heller by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Cottrell, Frederick) (Entered: 03/17/2023) (0) |
| Mar 17, 2023 | 136 | NOTICE of Subpoena to Produce Documents, Information, or Objects or to Permit for Inspection, for WellSpan York Hospital by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Attachments: # 1 Exhibit 1)(Cottrell, Frederick) (Entered: 03/17/2023) (0) |
| Mar 16, 2023 | 131 | Letter to The Honorable Jennifer L. Hall, from Defendants, regarding request for leave to amend answers and counterclaims. (Attachments: # 1 Exhibits 1 -11, # 2 Illumina's Proposed Order, # 3 Roche's Proposed Order, # 4 FMI's Proposed Order, # 5 Biora's Proposed Order)(Joyce, Alexandra) Modified on 3/16/2023 (nms). (Entered: 03/16/2023) (0) |
| Mar 14, 2023 | 130 | ORAL ORDER granting Defendants' Joint Motion to Join March 29, 2023 Teleconference to Resolve Disputes Regarding Motions to Amend Answers (C.A. 20-1644, D.I. 87; C.A. 20-1646, D.I. 129). The Court approves the proposed letter briefing schedule. Ordered by Judge Jennifer L. Hall on 3/14/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH(ceg) (Entered: 03/14/2023) (0) |
| Mar 13, 2023 | 129 | Joint Motion to Join March 29, 2023 Teleconference to Resolve Disputes Regarding Motions to Amend Answers - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. Motions referred to Jennifer L. Hall. (Cottrell, Frederick) Modified docket text on 3/14/2023 (ceg). (Entered: 03/13/2023) (3) |
| Mar 8, 2023 | 128 | MOTION for Pro Hac Vice Appearance of Attorney Benjamin N. Luehrs and Kyle G. Petrie - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Michael) (Entered: 03/08/2023) (4) |
| Mar 7, 2023 | 127 | ORAL ORDER Setting Telephonic Scheduling Conference: A Scheduling Conference is scheduled for March 10, 2023 at 10:00 AM before Judge Jennifer L. Hall. The parties shall call the Court's conference line at (877) 336-1829, access code: 7090640. Ordered by Judge Jennifer L. Hall on 3/7/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/07/2023) (0) |
| Mar 6, 2023 | 126 | PROPOSED Amended Scheduling Order by Ravgen, Inc. (Attachments: # 1 Letter to The Honorable Jennifer L. Hall)(Farnan, Michael) Modified docket text on 3/6/2023 (ceg). (Entered: 03/06/2023) (0) |
| Feb 27, 2023 | 125 | STIPULATION Extending Deadline to Submit a Scheduling Order to 3/6/2023 - filed by Ravgen, Inc.. (Farnan, Michael) Modified on 2/28/2023 (nms). (Entered: 02/27/2023) (3) |
| Feb 23, 2023 | 123 | NOTICE of Appearance by Christine Dealy Haynes on behalf of Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Haynes, Christine) (Entered: 02/23/2023) (1) |
| Feb 23, 2023 | 124 | NOTICE of Appearance by Christine Dealy Haynes on behalf of Foundation Medicine, Inc. (Haynes, Christine) (Entered: 02/23/2023) (1) |
| Feb 13, 2023 | 122 | ORAL ORDER: The request to lift the stay (D.I. 79 ) is GRANTED. The parties shall meet and confer and submit a proposed scheduling order on or before February 27, 2023. ORDERED by Judge Jennifer L. Hall on 2/13/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 02/13/2023) (0) |
| Feb 6, 2023 | 121 | JOINT Status Report, by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Brian) Modified on 2/7/2023 (nms). (Entered: 02/06/2023) (0) |
| Feb 1, 2023 | 120 | STIPULATION Extending Deadline to Submit Status Report to February 6, 2023 - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Cottrell, Frederick) Modified on 2/2/2023 (nms). (Entered: 02/01/2023) (3) |
| Jan 9, 2023 | 119 | ORAL ORDER: The parties shall file an updated status report on February 2, 2023. ORDERED by Judge Jennifer L. Hall on 1/9/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 01/09/2023) (0) |
| Jan 4, 2023 | 118 | Joint Status Report, by Ravgen, Inc.. (Farnan, Brian) Modified on 1/4/2023 (nms). (Entered: 01/04/2023) (10) |
| Dec 21, 2022 | 117 | STIPULATION to Extend Time to submit status report - filed by Ravgen, Inc.. (Farnan, Michael) Modified on 12/21/2022 (nms). (Entered: 12/21/2022) (3) |
| Nov 11, 2022 | 116 | Status Report (Main Document) (12) Docket Text: JOINT Status Report, by Ravgen, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Farnan, Brian) Modified on 11/14/2022 (nms). |
| Nov 11, 2022 | 116 | Status Report (Exhibit A) (30) Docket Text: JOINT Status Report, by Ravgen, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Farnan, Brian) Modified on 11/14/2022 (nms). |
| Nov 11, 2022 | 116 | Status Report (Exhibit B) (30) Docket Text: JOINT Status Report, by Ravgen, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Farnan, Brian) Modified on 11/14/2022 (nms). |
| Nov 11, 2022 | 116 | Status Report (Exhibit C) (30) Docket Text: JOINT Status Report, by Ravgen, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Farnan, Brian) Modified on 11/14/2022 (nms). |
| Nov 9, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation and Order to Extend Time for the parties to file a joint status report to November 11, 2022. (73 in 1:20-cv-01644-RGA-JLH, 115 in 1:20-cv-01646-RGA-JLH, 77 in 1:20-cv-01730-RGA-JLH, 67 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/9/2022. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Nov 8, 2022 | 115 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a joint status report to November 11, 2022 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc., Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc., Illumina, Inc., Verinata Health, Inc., Progenity, Inc.. (Tigan, Jeremy) |
| Jul 29, 2022 | 113 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Renee Mosley Delcollo as co-counsel. Reason for request: leaving firm. (Delcollo, Renee) |
| Jul 29, 2022 | 114 | Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Renee Mosley Delcollo as co-counsel. Reason for request: leaving firm. (Delcollo, Renee) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel) |
| Mar 14, 2022 | 112 | SO ORDERED (4) Docket Text: SO ORDERED, [109] Stipulation Regarding Limited IPR Estoppel Applicable to Non-Petitioner Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., Roche Molecular Systems, Inc., Foundation Medicine, Inc. and Progenity, Inc. Signed by Judge Jennifer L. Hall on 3/14/2022. (ceg) |
| Mar 10, 2022 | 111 | Letter (3) Docket Text: Letter to The Honorable Jennifer L. Hall, from Frederick L. Cottrell, III, regarding stipulations for limited IPR estoppel. (Cottrell, Frederick) Modified on 3/10/2022 (nms). |
| Mar 9, 2022 | 110 | Letter (2) Docket Text: Letter to The Honorable Jennifer L. Hall, from Michael J. Farnan, regarding stipulations for limited IPR estoppel. (Farnan, Michael) Modified on 3/9/2022 (nms). |
| Mar 8, 2022 | 109 | Stipulation (4) Docket Text: STIPULATION Regarding Limited IPR Estoppel Applicable to Non-Petitioner Defendants by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) |
| Mar 1, 2022 | N/A | Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Motion Hearing held on 3/1/2022 via video conference re Defendant Myriad's Motion to Stay (C.A. No. 20-1730, D.I. 52), and the Notices of Joinder filed by Defendants Ilumina (C.A. No. 20-1644, D.I. 59), Roche, FMI (C.A. No. 1646, D.I. 100), and Progenity (C.A. No. 20-1734, D.I. 54) (*Court Reporter Jennifer Guy.) Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Mar 1, 2022 | N/A | Order on Motion to Stay (0) Docket Text: ORAL ORDER: For the reasons announced from the bench at the March 1, 2022 hearing, Defendants' Motions to Stay (C.A. No. 20-1730, D.I. 52; C.A. No. 20-1644, D.I. 59; C.A. No. 20-1646, D.I. 100; C.A. No. 20-1734, D.I. 54) are GRANTED subject to non-petitioner Defendants filing within 7 days a stipulation of estoppel consistent with the hearing today. Within 7 days of any final written decision from the PTAB in any related IPR, the parties shall submit a joint status report to the Court indicating whether they wish to extend the stay. If the parties are not in agreement, the joint status report should include at least an updated chart of challenged claims and IPR decisions similar to the chart in the previous joint letter (C.A. No. 20-1730, D.I. 72) and should set forth the parties' positions. ORDERED by Judge Jennifer L. Hall on 3/1/2022. Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Feb 28, 2022 | 106 | Letter (6) Docket Text: Letter to The Honorable Jennifer L. Hall, from Frederick L. Cottrell, III, regarding response to the Court's Oral Order of February 24, 2022. (Cottrell, Frederick) Modified on 2/28/2022 (ceg). Modified on 2/28/2022 (nms). |
| Feb 28, 2022 | 107 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Brian G. Van Ness, Ph.D. on March 1, 2022 filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) |
| Feb 24, 2022 | N/A | Order Setting Hearing on Motion (0) Docket Text: ORAL ORDER Setting Hearing on Motions: Having reviewed Defendant Myriad's Motion to Stay (C.A. No. 20-1730, D.I. 52), and the briefing filed in support thereof and in opposition thereto, and having reviewed the Notices of Joinder filed by Defendants Ilumina (C.A. No. 20-1644, D.I. 59), Roche, FMI (C.A. No. 1646, D.I. 100), and Progenity (C.A. No. 20-1734, D.I. 54) it is HEREBY ORDERED that a brief hearing on the motions is scheduled for March 1, 2022 at 9:00 AM via video conference before Judge Jennifer L. Hall. On or before noon on February 28, 2022, the parties shall send a joint email to Cailah_Garfinkel@ded.uscourts.gov containing the following information: (1) a video conference link with instructions on how to join the conference; (2) a separate audio-only dial-in; and (3) a list of attendees for each party, specifying who will be speaking on behalf of each party. Any video conference must be sufficient to accommodate Judge Hall, the courtroom deputy, a law clerk, and the court reporter. Also, on or before noon on February 28, 2022, the parties shall meet and confer and file a joint letter setting forth the following: (A) a chart that will enable the Court to easily identify which claims are asserted against each party in these litigations, which claims are at issue in the reexamination(s), which claims are at issue in the instituted IPRs and the IPRs for which an institution decision is still pending, and which claims are at issue in this litigation but are not otherwise being challenged at the PTO; and (B) whether the parties can agree on the scope of estoppel that should apply to the non-petitioner defendants if a stay is granted and, if not, the parties' respective positions on any estoppel that should be required as a condition of any stay entered by the Court. ORDERED by Judge Jennifer L. Hall on 2/24/2022. Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Feb 24, 2022 | 103 | Statement (9) Docket Text: OPPOSITION to [100] Joinder, by Ravgen, Inc.. (Farnan, Brian) Modified on 2/24/2022 (nms). |
| Feb 24, 2022 | 105 | Redacted Document (Main Document) (4) Docket Text: REDACTED VERSION of [104] Declaration, by Ravgen, Inc.. (Attachments: # (1) Exhibits 1-10, # (2) Certificate of Service)(Farnan, Brian) Modified on 2/24/2022 (nms). |
| Feb 24, 2022 | 105 | Redacted Document (Exhibits 1-10) (30) Docket Text: REDACTED VERSION of [104] Declaration, by Ravgen, Inc.. (Attachments: # (1) Exhibits 1-10, # (2) Certificate of Service)(Farnan, Brian) Modified on 2/24/2022 (nms). |
| Feb 24, 2022 | 105 | Redacted Document (Certificate of Service) (2) Docket Text: REDACTED VERSION of [104] Declaration, by Ravgen, Inc.. (Attachments: # (1) Exhibits 1-10, # (2) Certificate of Service)(Farnan, Brian) Modified on 2/24/2022 (nms). |
| Feb 18, 2022 | 101 | Disclosure Statement (2) Docket Text: Amended Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Novartis AG for Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.; Other Affiliate OPKO Health, Inc. for Ariosa Diagnostics, Inc. filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) |
| Feb 11, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [99] Stipulation to Extend Time to Substantially Complete Document Production Requests Served by November 5, 2021 to March 15, 2022. ORDERED by Judge Jennifer L. Hall on 2/11/2022. (ceg) |
| Feb 11, 2022 | 100 | Motion - Miscellaneous (Main Document) (5) Docket Text: JOINDER in Motion to Stay, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) 7.1.1 Certification, # (2) Proposed Order)(Delcollo, Renee) Modified on 2/14/2022 (nms). Modified on 3/1/2022 (ceg). |
| Feb 11, 2022 | 100 | Motion - Miscellaneous (7.1.1 Certification) (1) Docket Text: JOINDER in Motion to Stay, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) 7.1.1 Certification, # (2) Proposed Order)(Delcollo, Renee) Modified on 2/14/2022 (nms). Modified on 3/1/2022 (ceg). |
| Feb 11, 2022 | 100 | Motion - Miscellaneous (Text of Proposed Order) (2) Docket Text: JOINDER in Motion to Stay, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) 7.1.1 Certification, # (2) Proposed Order)(Delcollo, Renee) Modified on 2/14/2022 (nms). Modified on 3/1/2022 (ceg). |
| Feb 9, 2022 | 99 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Substantially Complete Document Production Requests Served by November 5, 2021 to March 15, 2022 - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) |
| Jan 21, 2022 | 98 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendants' Answering Claim Construction Brief, (2) Declaration of Omar A. Khan in Support of Defendants' Answering Claim Construction Brief, and (3) Declaration of Dr. Michael L. Metzker in Support of Answering Claim Construction Brief filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Delcollo, Renee) |
| Jan 19, 2022 | 97 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendant Foundation Medicine, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-101) filed by Ravgen, Inc..(Farnan, Michael) |
| Dec 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation and Order to Extend Time (96 in 1:20-cv-01646-RGA-JLH, 52 in 1:20-cv-01734-RGA-JLH, 56 in 1:20-cv-01644-RGA-JLH, 59 in 1:20-cv-01730-RGA-JLH). *Reset Deadlines for Claim Construction Briefing: Claim Construction Answering Brief due by 1/21/2022; Claim Construction Reply Brief due by 2/11/2022; Claim Construction Surreply Brief due by 3/4/2022; Joint Claim Construction Brief; Tutorial on the technology due by 3/9/2022. ORDERED by Judge Jennifer L. Hall on 12/29/2021. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Dec 21, 2021 | 96 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) Modified on 12/23/2021 (nms). |
| Dec 20, 2021 | 93 | SO ORDERED (24) Docket Text: SO ORDERED, re Agreement regarding Discovery of Electronically Stored Information and Order. (92 in 1:20-cv-01646-RGA-JLH, 53 in 1:20-cv-01644-RGA-JLH). Signed by Judge Jennifer L. Hall on 12/20/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH(ceg) |
| Dec 20, 2021 | 94 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendants Ariosa Diagnostics, Inc.'s, Roche Sequencing Solutions, Inc.'s, and Roche Molecular Systems, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-122) filed by Ravgen, Inc..(Farnan, Brian) |
| Dec 20, 2021 | 95 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Foundation Medicine, Inc.'s First Set of Requests for Production to Plaintiff Ravgen, Inc. (Nos. 1-101) filed by Foundation Medicine, Inc..(Delcollo, Renee) |
| Dec 16, 2021 | 90 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections and Responses to Ravgen's First Set of Requests for the Production of Documents and Things (Nos. 1-72) filed by Foundation Medicine, Inc..(Delcollo, Renee) |
| Dec 16, 2021 | 91 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Objections and Responses to Ravgen's First Set of Requests for the Production of Documents and Things (Nos. 1-72) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Delcollo, Renee) |
| Dec 16, 2021 | 92 | Proposed Order (24) Docket Text: PROPOSED Agreement Regarding Discovery of Electronically Stored Information and Proposed Order, by Ravgen, Inc.. (Farnan, Brian) Modified on 12/17/2021 (nms). |
| Dec 10, 2021 | 89 | SO ORDERED (30) Docket Text: SO ORDERED, re Stipulated Protective Order. (88 in 1:20-cv-01646-RGA-JLH, 49 in 1:20-cv-01734-RGA-JLH, 50 in 1:20-cv-01644-RGA-JLH, 54 in 1:20-cv-01730-RGA-JLH). Signed by Judge Jennifer L. Hall on 12/10/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Dec 8, 2021 | 88 | Proposed Order (30) Docket Text: PROPOSED Stipulated Protective Order by Ravgen, Inc. (Farnan, Brian) Modified on 12/8/2021 (ceg). |
| Nov 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time to submit the proposed Protective Order to 12/8/2021. (87 in 1:20-cv-01646-RGA-JLH, 49 in 1:20-cv-01644-RGA-JLH, 48 in 1:20-cv-01734-RGA-JLH, 51 in 1:20-cv-01730-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/29/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Nov 23, 2021 | 87 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 12/8/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Nov 17, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jonathan Swisher for Foundation Medicine, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Nov 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [86] Motion for Pro Hac Vice Appearance of Attorney Jonathan Swisher filed by Foundation Medicine, Inc. ORDERED by Judge Jennifer L. Hall on 11/16/2021. (ceg) |
| Nov 16, 2021 | 86 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jonathan Swisher - filed by Foundation Medicine, Inc.. Motions referred to Jennifer L. Hall.(Delcollo, Renee) |
| Nov 12, 2021 | 83 | Claim Construction Chart (Main Document) (21) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 1) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 2) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 3) (19) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 4) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 5) (9) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 6) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 7) (6) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 8) (30) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 9) (6) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 10) (19) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 11) (24) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 12) (15) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 13) (23) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 83 | Claim Construction Chart (Exhibit 14) (13) Docket Text: JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Main Document) (21) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 15) (26) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 16) (7) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 17) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 18) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 19) (28) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 20) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 21) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 22) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 23) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 24) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 25) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 26) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 27) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 84 | Claim Construction Chart (Exhibit 28) (30) Docket Text: JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # (1) Exhibit 15, # (2) Exhibit 16, # (3) Exhibit 17, # (4) Exhibit 18, # (5) Exhibit 19, # (6) Exhibit 20, # (7) Exhibit 21, # (8) Exhibit 22, # (9) Exhibit 23, # (10) Exhibit 24, # (11) Exhibit 25, # (12) Exhibit 26, # (13) Exhibit 27, # (14) Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Main Document) (21) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 29) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 30) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 31) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 32) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 33) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 34) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 35) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 36) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 37) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 38) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 39) (9) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 40) (7) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 12, 2021 | 85 | Claim Construction Chart (Exhibit 41) (30) Docket Text: JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # (1) Exhibit 29, # (2) Exhibit 30, # (3) Exhibit 31, # (4) Exhibit 32, # (5) Exhibit 33, # (6) Exhibit 34, # (7) Exhibit 35, # (8) Exhibit 36, # (9) Exhibit 37, # (10) Exhibit 38, # (11) Exhibit 39, # (12) Exhibit 40, # (13) Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). |
| Nov 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time to file a joint claim construction chart to November 12, 2021. (43 in 1:20-cv-01734-RGA-JLH, 46 in 1:20-cv-01730-RGA-JLH, 43 in 1:20-cv-01644-RGA-JLH, 77 in 1:20-cv-01646-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/10/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Nov 10, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Parties' proposals regarding the claim construction briefing structure and limitations. (See Letter at 47 in 1:20-cv-01730-RGA-JLH, 79 in 1:20-cv-01646-RGA-JLH, 44 in 1:20-cv-01734-RGA-JLH, 44 in 1:20-cv-01644-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/10/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Nov 10, 2021 | 82 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Marty Koresawa as Counsel by Foundation Medicine, Inc. (Cottrell, Frederick) |
| Nov 9, 2021 | 80 | Answer to Amended Complaint (24) Docket Text: ANSWER to [33] Amended Complaint, by Foundation Medicine, Inc..(Cottrell, Frederick) Modified on 11/10/2021 (nms). |
| Nov 9, 2021 | 81 | Answer to Amended Complaint (25) Docket Text: ANSWER to [33] Amended Complaint, by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Cottrell, Frederick) Modified on 11/10/2021 (nms). |
| Nov 5, 2021 | 77 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to file a joint claim construction chart to November 12, 2021 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Tigan, Jeremy) |
| Nov 5, 2021 | 78 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Ariosa Diagnostics, Inc.'s, Roche Sequencing Solutions, Inc.'s and Roche Molecular Systems, Inc.'s First Set of Requests for Production of Documents and Things from Plaintiff Ravgen, Inc. (Nos. 1-122) filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Delcollo, Renee) |
| Nov 5, 2021 | 79 | Letter (1) Docket Text: Letter to The Honorable Jennifer L. Hall from Brian E. Farnan regarding Proposal for Claim Construction Briefs. (Farnan, Brian) |
| Nov 2, 2021 | 76 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-72) filed by Ravgen, Inc..(Farnan, Brian) |
| Oct 29, 2021 | 74 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Ravgen's Proposed Claim Constructions filed by Ravgen, Inc..(Farnan, Brian) |
| Oct 29, 2021 | 75 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Identification of Proposed Constructions filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Delcollo, Renee) |
| Oct 26, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: I have considered the Report and Recommendation (D.I. [60]), FMIs objection (D.I. [59]), and Ravgens response (D.I. [63]). In light of Wrinkl, Inc. v. Facebook, Inc., 2021 WL 4477022, at *6 (D. Del. Sept. 30, 2021), FMIs objection (D.I. [59]) is overruled. The Report and Recommendation (D.I. [60]) is ADOPTED. The motions to dismiss (D.I. [23], D.I. [25]) are DENIED. Ordered by Judge Richard G. Andrews on 10/26/2021. (nms) |
| Oct 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [70] STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 11/24/2021., [71] STIPULATION TO EXTEND TIME for the parties' deadline to exchange proposed claim constructions to October 29, 2021. ORDERED by Judge Jennifer L. Hall on 10/25/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH. (cna, ) |
| Oct 22, 2021 | 70 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 11/24/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Oct 22, 2021 | 71 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties' deadline to exchange proposed claim constructions to October 29, 2021 - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) |
| Oct 1, 2021 | 68 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Ravgen's Identification of Claim Terms for Construction filed by Ravgen, Inc..(Farnan, Brian) |
| Oct 1, 2021 | 69 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Identification of Claim Terms and Phrases for Construction filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Cottrell, Frederick) |
| Sep 27, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time to submit a Proposed Protective Order to 10/25/2021. (67 in 1:20-cv-01646-RGA-JLH, 34 in 1:20-cv-01644-RGA-JLH, 36 in 1:20-cv-01730-RGA-JLH, 33 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 9/27/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Sep 24, 2021 | 67 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to 10/25/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Sep 17, 2021 | 66 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Cottrell, Frederick) |
| Aug 31, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time on Certain Scheduling Order Deadlines. (34 in 1:20-cv-01730-RGA-JLH, 65 in 1:20-cv-01646-RGA-JLH, 32 in 1:20-cv-01644-RGA-JLH, 31 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 8/31/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) Modified on 8/31/2021 (ceg). |
| Aug 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time for the submission of the Proposed Protective Order to 9/24/2021. (30 in 1:20-cv-01734-RGA-JLH, 33 in 1:20-cv-01730-RGA-JLH, 64 in 1:20-cv-01646-RGA-JLH, 31 in 1:20-cv-01644-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 8/30/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Aug 27, 2021 | 65 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION to Extend Time on Certain Scheduling Order Deadlines - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) Modified docket text on 8/31/2021 (ceg). |
| Aug 26, 2021 | 64 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the submission of the proposed Protective Order to 9/24/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Aug 23, 2021 | 63 | Response to Objections (7) Docket Text: RESPONSE to [59] Objections, by Ravgen, Inc.. (Farnan, Brian) Modified on 8/24/2021 (nms). |
| Aug 12, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: I read the Report and Recommendations filed August 11, 2021. (D.I. [60]). There are objections, which will be briefed. But I noted that two of the recommendations are plainly right. Thus, the motions to dismiss (D.I. [12], [15]) that were filed before the Second Amended Complaint was filed are moot. They therefore are DISMISSED as moot. Ordered by Judge Richard G. Andrews on 8/12/2021. (lak) |
| Aug 11, 2021 | 60 | Report and Recommendations (9) Docket Text: REPORT AND RECOMMENDATIONS re Motions to Dismiss the Original Complaint (D.I. 12; D.I. 15), and Motions to Dismiss the Second Amended Complaint (D.I. 23; D.I. 25 ). Signed by Judge Jennifer L. Hall on 8/11/2021. (ceg) |
| Aug 11, 2021 | 61 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Renee Mosley Delcollo, regarding courtesy copies. (Delcollo, Renee) Modified on 8/11/2021 (nms). |
| Aug 9, 2021 | 59 | Objections (14) Docket Text: OBJECTIONS to [55] Oral Order, by Foundation Medicine, Inc.. (Cottrell, Frederick) Modified on 8/10/2021 (nms). |
| Aug 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [58] Stipulation and Order regarding Response Deadline. Defendants shall respond to the Second Amended Complaint 14 days after the Court issues a ruling on any objections to the July 26, 2021 Report and Recommendation. ORDERED by Judge Jennifer L. Hall on 8/5/2021. (ceg) |
| Aug 3, 2021 | 58 | Stipulation (1) Docket Text: STIPULATION Regarding Response Deadline by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) |
| Jul 30, 2021 | 57 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Ravgen's Initial Infringement Contentions filed by Ravgen, Inc..(Farnan, Brian) |
| Jul 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time for the submission of the Proposed Protective Order to 8/27/2021. (31 in 1:20-cv-01730-RGA-JLH, 29 in 1:20-cv-01644-RGA-JLH, 56 in 1:20-cv-01646-RGA-JLH, 28 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 7/29/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Jul 28, 2021 | 56 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the submission of the proposed Protective Order to 8/27/2021 - filed by Ravgen, Inc.. (Farnan, Michael) |
| Jul 26, 2021 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephone Conference held on 7/26/2021. The Court issued its Report and Recommendation from the bench. (*Court Reporter Jennifer Guy.) (ceg) |
| Jul 26, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER re REPORT AND RECOMMENDATION: For the reasons announced from the bench at today's teleconference, the Court recommends that the pending motions to dismiss the original Complaint (D.I. [12]; D.I. [15]) be DENIED as moot, and the pending motions to dismiss the Second Amended Complaint (D.I. [23]; D.I. [25]) be DENIED. The Court anticipates that it will file on the docket a written document incorporating a transcript of its oral ruling; however, any objections to the Court's Report and Recommendation shall be filed within fourteen days from today. The parties are directed to the Court's "Standing Order for Objections Filed Under Fed. R. Civ. P. 72," dated October 9, 2013, a copy of which can be found on the Courts website. ORDERED by Judge Jennifer L. Hall on 7/26/2021. (ceg) |
| Jul 23, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Paul Samuel Callaghan for Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jul 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation to Extend Time to Submit the Proposed Protective Order to 7/30/2021. (51 in 1:20-cv-01646-RGA-JLH, 27 in 1:20-cv-01644-RGA-JLH, 26 in 1:20-cv-01734-RGA-JLH, 28 in 1:20-cv-01730-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 7/15/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Jul 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re Stipulation Amending Scheduling Order. (27 in 1:20-cv-01734-RGA-JLH, 52 in 1:20-cv-01646-RGA-JLH, 29 in 1:20-cv-01730-RGA-JLH, 28 in 1:20-cv-01644-RGA-JLH).. ORDERED by Judge Jennifer L. Hall on 7/15/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Jul 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [53] Stipulation and Order of Partial Dismissal as to Defendant Foundation Medicine, Inc. ORDERED by Judge Jennifer L. Hall on 7/15/2021. (ceg) |
| Jul 15, 2021 | N/A | Order Setting Teleconference (0) Docket Text: ORAL ORDER Setting Teleconference: A telephone conference is set for July 26, 2021 at 4:00 p.m. at which time the Court anticipates reading from the bench its report and recommendation regarding the pending motions to dismiss (D.I. [12], [15], [23], [25]). The parties shall call the Court's conference line at (877) 336-1829, access code: 7090640. ORDERED by Judge Jennifer L. Hall on 7/15/2021. (ceg) |
| Jul 13, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [50] Motion for Pro Hac Vice Appearance of Attorney Paul Samuel Callaghan filed by Roche Sequencing Solutions, Inc., Ariosa Diagnostics, Inc., Roche Molecular System, Inc. ORDERED by Judge Jennifer L. Hall on 7/13/2021. (ceg) |
| Jul 13, 2021 | 50 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Paul Samuel Callaghan - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. Motions referred to Jennifer L. Hall.(Delcollo, Renee) |
| Jul 13, 2021 | 51 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 7/30/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Jul 13, 2021 | 52 | Stipulation (3) Docket Text: STIPULATION Amending Scheduling Order by Ravgen, Inc.. (Farnan, Brian) |
| Jul 13, 2021 | 53 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order of Partial Dismissal by Foundation Medicine, Inc.. (Delcollo, Renee) |
| Jul 1, 2021 | N/A | Motion Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Motion Hearing held by video conference on 7/1/2021 re Motion to Dismiss First Amended Complaint (D.I. 23) and Motion to Dismiss Willful Infringement and Induced Infringement Claims (D.I. 25). (*Court Reporter Stacy Ingram.) (ceg) |
| Jun 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, Stipulation to Extend Time to submit a Proposed Protective Order to 7/16/2021. (49 in 1:20-cv-01646-RGA-JLH, 27 in 1:20-cv-01730-RGA-JLH, 26 in 1:20-cv-01644-RGA-JLH, 25 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 6/30/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Jun 30, 2021 | 49 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to 7/16/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Jun 21, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, Stipulation to Extend Time for the submission of the proposed Protective Order to 7/2/2021. (25 in 1:20-cv-01644-RGA-JLH, 26 in 1:20-cv-01730-RGA-JLH, 48 in 1:20-cv-01646-RGA-JLH, 24 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 6/21/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Jun 16, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 6/16/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(Taylor, Daniel) |
| Jun 16, 2021 | 48 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the submission of the proposed Protective Order to 7/2/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Jun 4, 2021 | 46 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Core Technical Documents filed by Foundation Medicine, Inc..(Cottrell, Frederick) |
| Jun 4, 2021 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Core Technical Documents filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Cottrell, Frederick) |
| Jun 1, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Peter Zhu,Jun Tong,Joze Welsh for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH (myr) |
| May 25, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, Motion for Pro Hac Vice Appearance of Attorney Peter Zhu, Jun Tong, and Joze Welsh filed by Ravgen, Inc. (24 in 1:20-cv-01730-RGA-JLH, 22 in 1:20-cv-01734-RGA-JLH, 24 in 1:20-cv-01644-RGA-JLH, 45 in 1:20-cv-01646-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 5/25/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| May 25, 2021 | 45 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Peter Zhu, Jun Tong, and Joze Welsh - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Brian) |
| May 19, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(Taylor, Daniel) |
| May 19, 2021 | 44 | Scheduling Order (18) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties and Amendment of Pleadings due by 7/26/2022. Fact Discovery completed by 8/16/2022. Opening Expert Reports due by 10/3/2022. Rebuttal Expert Reports due by 11/17/2022. Expert Discovery due by 2/9/2023. Interim Status Report due by 3/15/2022. Dispositive Motions due by 3/9/2023. Answering Brief due 4/6/2023. Reply Brief due 4/20/2023. A Motion Hearing is set for 5/5/2023 at 01:00 PM before Judge Jennifer L. Hall. Joint Claim Construction Brief due by 3/3/2022. A Markman Hearing is set for 4/12/2022 at 01:00 PM before Judge Jennifer L. Hall. A Trial Ordering and Scheduling Conference is set for 3/2/2023 at 01:00 PM before Judge Jennifer L. Hall. Proposed Final Pretrial Order due by 8/21/2023. A Pretrial Conference is set for 8/25/2023 at 09:00 AM before Judge Richard G. Andrews. A 5 day Jury Trial is set for 9/11/2023 at 09:30 AM in Courtroom 6A before Judge Richard G. Andrews. (*See Order for complete details). Signed by Judge Jennifer L. Hall on 5/19/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| May 12, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The cover letter attached to the revised scheduling order has been replaced per the filing party's request. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| May 11, 2021 | 43 | Proposed Order (Main Document) (18) Docket Text: PROPOSED Scheduling Order, by Ravgen, Inc.. (Attachments: # (1) Letter)(Farnan, Brian) (Attachment 1 replaced on 5/12/2021) (ceg). |
| May 11, 2021 | 43 | Proposed Order (Letter to The Honorable Jennifer L. Hall) (1) Docket Text: PROPOSED Scheduling Order, by Ravgen, Inc.. (Attachments: # (1) Letter)(Farnan, Brian) (Attachment 1 replaced on 5/12/2021) (ceg). |
| May 3, 2021 | 42 | Notice Requesting Removal of Co-Counsel (3) Docket Text: NOTICE requesting Clerk to remove Michael Ling as co-counsel.. (Farnan, Brian) |
| Apr 30, 2021 | 39 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (i) Plaintiff's Initial Disclosures Pursuant to Fed. R. Civ. P. 26; (ii) Ravgen's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI"); and (iii) Ravgen's Preliminary Identification of Asserted Patents and Accused Products filed by Ravgen, Inc..(Farnan, Brian) |
| Apr 30, 2021 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Foundation Medicine, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1)(a) and (2) Defendant Foundation Medicine, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Court's Default Standard for Discovery filed by Foundation Medicine, Inc..(Cottrell, Frederick) |
| Apr 30, 2021 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Ariosa Diagnostics, Inc.'s Roche Sequencing Solutions, Inc.'s and Roche Molecular Systems, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Ariosa Diagnostics, Inc.'s Roche Sequencing Solutions, Inc.'s and Roche Molecular Systems, Inc.'s ESI Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Cottrell, Frederick) |
| Apr 27, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jennifer A. Sklenar for Foundation Medicine, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Apr 27, 2021 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephonic Scheduling Conference held on 4/27/2021. (*Court Reporter Jennifer Guy.) Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Apr 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that, as discussed at the scheduling conference, on or before May 11, 2021, the parties shall submit a final version of the scheduling order. ORDERED by Judge Jennifer L. Hall on 4/27/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Apr 26, 2021 | N/A | Order Setting Hearing on Motion (0) Docket Text: ORAL ORDER Setting Hearing on Motions: A hearing on the pending Motion to Dismiss First Amended Complaint (D.I. [23]) and Motion to Dismiss Willful Infringement and Induced Infringement Claims (D.I. [25]) is scheduled for Thursday, July 1, 2021 at 2:00 PM Eastern Time via video conference before Judge Jennifer L. Hall. The parties shall send a joint email to Cailah_Garfinkel@ded.uscourts.gov containing the following information regarding oral argument on or before June 29, 2021: (1) a video conference link with instructions on how to join the conference; (2) a separate audio-only dial-in; and (3) a list of attendees for each party, specifying who will be presenting argument. Any video conference must be sufficient to accommodate Judge Hall, the courtroom deputy, a law clerk, and the court reporter. Any slide presentations or demonstratives that the parties wish to use during the hearing shall be emailed to Cailah_Garfinkel@ded.uscourts.gov no later than 24 hours prior to the hearing. Slide presentations or demonstratives may be presented by the parties on the video conference screen or referred to by the parties at the hearing. Once the dial-in information is received by the Court, members of the public may obtain it by contacting Chambers at Cailah_Garfinkel@ded.uscourts.gov. All participants (including any media and members of the public) are reminded that recording or broadcasting proceedings is STRICTLY PROHIBITED. All participants shall be present on the video conference no later than 10 minutes prior to the start of the hearing. ORDERED by Judge Jennifer L. Hall on 4/26/2021. (ceg) |
| Apr 26, 2021 | 36 | Reply Brief (15) Docket Text: REPLY BRIEF re [23] MOTION to Dismiss First Amended Complaint filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) |
| Apr 26, 2021 | 37 | Reply Brief (13) Docket Text: REPLY BRIEF re [25] MOTION to Dismiss Willful Infringement and Induced Infringement Claims filed by Foundation Medicine, Inc.. (Delcollo, Renee) |
| Apr 23, 2021 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER Setting Telephonic Scheduling Conference: A Scheduling Conference is scheduled for April 27, 2021 at 04:00 PM Eastern Time before Judge Jennifer L. Hall. Counsel for Plaintiff shall send dial-in information directly to the Court by 4:00 PM on April 26, 2021 using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. ORDERED by Judge Jennifer L. Hall on 4/23/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) |
| Apr 19, 2021 | 33 | Amended Complaint* (1) |
| Apr 19, 2021 | 33 | Amended Complaint (Main Document) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 1) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 2) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 3) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 4) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 5) (26) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 6) (6) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 7) (17) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 8) (7) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 9) (17) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 10) (9) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 11) (7) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 12) (6) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 13) (8) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 14) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 15) (9) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 16) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 17) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 18) (7) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 19) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 20) (9) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 21) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 22) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 23) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 24) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 25) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 26) (10) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 27) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 28) (6) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 29) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 30) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 31) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 32) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 33) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 34) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 35) (9) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 36) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 37) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 38) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 39) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 40) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 41) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 42) (15) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 43) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 44) (7) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 45) (7) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 46) (10) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 47) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 48) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 49) (13) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 50) (7) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 51) (7) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 52) (6) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 53) (6) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 54) (5) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 55) (8) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 56) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 57) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 58) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 59) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 60) (9) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 61) (3) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 62) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 63) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 64) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 65) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 66) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 67) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 68) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 69) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 70) (5) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 71) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 72) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 73) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 74) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 75) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 76) (4) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 77) (6) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 78) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 79) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 80) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 81) (2) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 19, 2021 | 33 | Amended Complaint (Exhibit 82) (30) Docket Text: SECOND AMENDED COMPLAINT for Patent Infringement against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) Modified on 4/19/2021 (nms). |
| Apr 16, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [32] Stipulation Concerning Second Amended Complaint. Plaintiff may file a Second Amended Complaint which solely replaces Exhibit 77. ORDERED by Judge Jennifer L. Hall on 4/16/2021. (ceg) |
| Apr 16, 2021 | 32 | Stipulation (2) Docket Text: STIPULATION regarding Second Amended Complaint by Ravgen, Inc.. (Farnan, Brian) |
| Apr 12, 2021 | 30 | Answering Brief in Opposition (24) Docket Text: ANSWERING BRIEF in Opposition re [23] MOTION to Dismiss First Amended Complaint filed by Ravgen, Inc..Reply Brief due date per Local Rules is 4/19/2021. (Farnan, Michael) |
| Apr 12, 2021 | 31 | Answering Brief in Opposition (26) Docket Text: ANSWERING BRIEF in Opposition re [25] MOTION to Dismiss Willful Infringement and Induced Infringement Claims filed by Ravgen, Inc..Reply Brief due date per Local Rules is 4/19/2021. (Farnan, Michael) |
| Apr 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [28] Stipulation to Extend Briefing Deadlines for Plaintiff to respond to Defendants' Motion to Dismiss and for Defendants to submit their Reply Briefs (*Reset Briefing Schedule: Answering Briefs due 4/12/2021; Reply Briefs due 4/26/2021). ORDERED by Judge Jennifer L. Hall on 4/5/2021. (ceg) |
| Mar 31, 2021 | 28 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME (i) for Plaintiff to respond to Defendants' Motion to Dismiss and (ii) for Defendants to submit their Reply Briefs to (i) 4/12/2021 and (ii) 4/26/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Mar 31, 2021 | 29 | Proposed Order (24) Docket Text: PROPOSED Scheduling Order, by Ravgen, Inc.. (Farnan, Brian) |
| Mar 26, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, Stipulation to Extend Time for the submission of the Proposed Scheduling Order and Joint Letter to 3/31/2021. (C.A. No. 20-1644, D.I. 14; C.A. No. 20-cv-1646, D.I. 27). ORDERED by Judge Jennifer L. Hall on 3/26/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH(ceg) |
| Mar 26, 2021 | 27 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the submission of the proposed Scheduling Order and joint letter to 3/31/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Mar 19, 2021 | 23 | Motion to Dismiss for Failure to State a Claim (Main Document) (1) Docket Text: MOTION to Dismiss First Amended Complaint - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) Proposed Order)Motions referred to Jennifer L. Hall.(Cottrell, Frederick) |
| Mar 19, 2021 | 23 | Motion to Dismiss for Failure to State a Claim (Text of Proposed Order Proposed Order) (1) Docket Text: MOTION to Dismiss First Amended Complaint - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) Proposed Order)Motions referred to Jennifer L. Hall.(Cottrell, Frederick) |
| Mar 19, 2021 | 24 | Opening Brief in Support (20) Docket Text: OPENING BRIEF in Support re [23] MOTION to Dismiss First Amended Complaint, filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..Answering Brief/Response due date per Local Rules is 4/5/2021. (Cottrell, Frederick) Modified on 3/22/2021 (nms). |
| Mar 19, 2021 | 25 | Motion to Dismiss for Failure to State a Claim (Main Document) (2) Docket Text: MOTION to Dismiss Willful Infringement and Induced Infringement Claims - filed by Foundation Medicine, Inc.. (Attachments: # (1) Proposed Order )Motions referred to Jennifer L. Hall.(Cottrell, Frederick) Modified on 3/22/2021 (nms). |
| Mar 19, 2021 | 25 | Motion to Dismiss for Failure to State a Claim (Text of Proposed Order Proposed Order) (1) Docket Text: MOTION to Dismiss Willful Infringement and Induced Infringement Claims - filed by Foundation Medicine, Inc.. (Attachments: # (1) Proposed Order )Motions referred to Jennifer L. Hall.(Cottrell, Frederick) Modified on 3/22/2021 (nms). |
| Mar 19, 2021 | 26 | Opening Brief in Support (21) Docket Text: OPENING BRIEF in Support re [25] MOTION to Dismiss Willful Infringement and Induced Infringement Claims, filed by Foundation Medicine, Inc..Answering Brief/Response due date per Local Rules is 4/5/2021. (Cottrell, Frederick) Modified on 3/22/2021 (nms). |
| Mar 15, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, Stipulation to Extend Time for the submission of the Proposed Scheduling Order and Joint Letter to 3/29/2021. (C.A. No. 20-cv-1644, D.I. 13; C.A. No. 20-cv-1646, D.I. 22; C.A. No 20-cv-1730, D.I. 12). ORDERED by Judge Jennifer L. Hall on 3/15/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH(ceg) |
| Mar 15, 2021 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the submission of the proposed Scheduling Order and joint letter to 3/29/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Mar 2, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [21] Stipulation and Order to Extend Time. The deadline for the parties to submit a proposed scheduling order is extended to 3/15/2021. The deadline for Defendants to answer the First Amended Complaint is extended to 3/19/2021. (*Reset Answer - Answer due 3/19/2021). ORDERED by Judge Jennifer L. Hall on 3/2/2021. (ceg) |
| Mar 1, 2021 | 21 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) Modified on 3/2/2021 (nms). |
| Feb 19, 2021 | 20 | Amended Complaint* (1) |
| Feb 19, 2021 | 20 | Amended Complaint (Main Document) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 1) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 2) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 3) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 4) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 5) (26) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 6) (6) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 7) (17) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 8) (7) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 9) (17) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 10) (9) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 11) (7) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 12) (6) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 13) (8) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 14) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 15) (9) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 16) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 17) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 18) (7) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 19) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 20) (9) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 21) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 22) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 23) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 24) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 25) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 26) (10) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 27) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 28) (6) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 29) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 30) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 31) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 32) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 33) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 34) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 35) (9) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 36) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 37) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 38) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 39) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 40) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 41) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 42) (15) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 43) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 44) (7) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 45) (7) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 46) (10) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 47) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 48) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 49) (13) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 50) (7) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 51) (7) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 52) (6) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 53) (6) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 54) (5) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 55) (8) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 56) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 57) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 58) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 59) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 60) (9) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 61) (3) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 62) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 63) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 64) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 65) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 66) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 67) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 68) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 69) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 70) (5) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 71) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 72) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 73) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 74) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 75) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 76) (4) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 77) (6) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 78) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 79) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 80) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 81) (2) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 19, 2021 | 20 | Amended Complaint (Exhibit 82) (30) Docket Text: First AMENDED COMPLAINT against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.- filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Exhibit 82)(Farnan, Brian) |
| Feb 12, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, [19] Stipulation to Extend Deadlines for: (i) Plaintiff to respond to Defendants' Motions to Dismiss and (ii) Defendants to file their Reply Briefs (*Reset Briefing Schedule: Answering Brief due 2/19/2021, Reply Brief due 3/5/2021). ORDERED by Judge Jennifer L. Hall on 2/12/2021. (ceg) |
| Feb 9, 2021 | 19 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to EXTEND deadlines for: (i) Plaintiff to respond to Defendants' Motions to Dismiss and (ii) Defendants to file their Reply Briefs to (i) 2/19/2021 and (ii) 3/5/2021 - filed by Ravgen, Inc.. (Farnan, Brian) |
| Feb 5, 2021 | N/A | Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent" up through and including paragraph number 17 (i.e., up to and including case dispositive motions) and consistent with paragraphs 13-16 of Judge Andrew's "Rule 16 Scheduling Order - Patent"; and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Orders can be found on Judge Hall's and Judge Andrew's portions of the District Court's website. ORDERED by Judge Jennifer L. Hall on 2/5/2021. (ceg) |
| Jan 29, 2021 | 12 | Motion to Dismiss for Failure to State a Claim (Main Document) (2) Docket Text: MOTION to Dismiss - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) Proposed Order)Motions referred to Jennifer L. Hall.(Cottrell, Frederick) Modified on 1/30/2021 (nms). |
| Jan 29, 2021 | 12 | Motion to Dismiss for Failure to State a Claim (Proposed Order) (1) Docket Text: MOTION to Dismiss - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # (1) Proposed Order)Motions referred to Jennifer L. Hall.(Cottrell, Frederick) Modified on 1/30/2021 (nms). |
| Jan 29, 2021 | 13 | Opening Brief in Support (18) Docket Text: OPENING BRIEF in Support re [12] MOTION to Dismiss, filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..Answering Brief/Response due date per Local Rules is 2/12/2021. (Cottrell, Frederick) Modified on 1/30/2021 (nms). |
| Jan 29, 2021 | 14 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Novartis AG for Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Cottrell, Frederick) |
| Jan 29, 2021 | 15 | Motion to Dismiss for Failure to State a Claim (Main Document) (2) Docket Text: MOTION to Dismiss - filed by Foundation Medicine, Inc.. (Attachments: # (1) Proposed Order)Motions referred to Jennifer L. Hall.(Cottrell, Frederick) Modified on 1/30/2021 (nms). |
| Jan 29, 2021 | 15 | Motion to Dismiss for Failure to State a Claim (Proposed Order) (1) Docket Text: MOTION to Dismiss - filed by Foundation Medicine, Inc.. (Attachments: # (1) Proposed Order)Motions referred to Jennifer L. Hall.(Cottrell, Frederick) Modified on 1/30/2021 (nms). |
| Jan 29, 2021 | 16 | Opening Brief in Support (16) Docket Text: OPENING BRIEF in Support re [15] MOTION to Dismiss, filed by Foundation Medicine, Inc..Answering Brief/Response due date per Local Rules is 2/12/2021. (Cottrell, Frederick) Modified on 1/30/2021 (nms). |
| Jan 29, 2021 | 17 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Novartis AG, Other Affiliate Roche Holding Ltd., Other Affiliate Roche Finance Ltd., Other Affiliate Roche Holdings, Inc. for Foundation Medicine, Inc. filed by Foundation Medicine, Inc.. (Cottrell, Frederick) |
| Jan 13, 2021 | N/A | Order Referring Case to Magistrate Judge (0) Docket Text: ORAL ORDER: The case is now referred to Magistrate Judge Jennifer L. Hall for all purposes through the case dispositive motion deadline. Ordered by Judge Richard G. Andrews on 1/13/2021. Associated Cases: 1:20-cv-01644-RGA, 1:20-cv-01646-RGA, 1:20-cv-01730-RGA, 1:20-cv-01734-RGA(nms) |
| Jan 4, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Matthew M. Wolf, Wallace W. Wu, Marty Koresawa, Victoria L. Reines, David McMullen for Foundation Medicine, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Dec 29, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Omar A. Khan, Scott G. Greene, Timothy A. Cook for Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Dec 29, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Robert J. Gunther, Jr and Christopher R. Noyes for Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Dec 28, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pro hac motion (D.I. 11) and the So Ordered entry that followed have been removed from the docket as counsel advised there were errors in the filing. (nms) |
| Dec 28, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Wolf, Wallace Wu, PhD, Jennifer Sklenar, Marty Koresawa, Victoria L. Reines and David McMullen, PhD, filed by Foundation Medicine, Inc.. Signed by Judge Richard G. Andrews on 12/28/2020. (nms) |
| Dec 28, 2020 | 11 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Matthew M. Wolf, Wallace Wu, PhD, Jennifer Sklenar, Marty Koresawa, Victoria L. Reines and David McMullen, PhD - filed by Foundation Medicine, Inc.. (Cottrell, Frederick) |
| Dec 23, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Robert J. Gunther Jr., Christopher R. Noyes, Omar A. Khan, Scott G. Greene and Timothy A. Coo, filed by Roche Sequencing Solutions, Inc., Ariosa Diagnostics, Inc., Roche Molecular System, Inc.. Signed by Judge Richard G. Andrews on 12/23/2020. (nms) Modified on 12/28/2020 (nms). |
| Dec 23, 2020 | 10 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert J. Gunther Jr., Christopher R. Noyes, Omar A. Khan, Scott G. Greene and Timothy A. Cook - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Cottrell, Frederick) Modified on 12/28/2020 (nms). |
| Dec 16, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kerri-Ann Limbeek,Michael Ling,Deborah J. Mariottini,Brian D. Matty,John M. Desmarais,Jamie L. Kringstein for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Dec 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Ariosa Diagnostics, Inc. answer due 1/29/2021; Foundation Medicine, Inc. answer due 1/29/2021; Roche Molecular System, Inc. answer due 1/29/2021; Roche Sequencing Solutions, Inc. answer due 1/29/2021). Signed by Judge Richard G. Andrews on 12/15/2020. (nms) |
| Dec 15, 2020 | 7 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME Answer to Complaint to through and including January 29, 2021 - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Cottrell, Frederick) |
| Dec 15, 2020 | 8 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Cottrell, Frederick) |
| Dec 15, 2020 | 9 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Renee Mosley Delcollo on behalf of Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Delcollo, Renee) |
| Dec 9, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:20-cv-01644-RGA, 1:20-cv-01646-RGA (rjb) |
| Dec 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (7 in 20-cv-1644-RGA; 6 in 20-cv-1646-RGA) MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, and Deborah J. Mariottini, filed by Ravgen, Inc.. Signed by Judge Richard G. Andrews on 12/9/2020. Associated Cases: 1:20-cv-01644-RGA, 1:20-cv-01646-RGA(nms) |
| Dec 9, 2020 | 6 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, and Deborah J. Mariottini - filed by Ravgen, Inc.. (Farnan, Brian) |
| Dec 4, 2020 | 4 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ravgen, Inc.. (Farnan, Michael) |
| Dec 4, 2020 | 5 | Summons Returned Executed (8) Docket Text: SUMMONS Returned Executed by Ravgen, Inc.. Ariosa Diagnostics, Inc. served on 12/4/2020, answer due 12/28/2020; Foundation Medicine, Inc. served on 12/4/2020, answer due 12/28/2020; Roche Molecular System, Inc. served on 12/4/2020, answer due 12/28/2020; Roche Sequencing Solutions, Inc. served on 12/4/2020, answer due 12/28/2020. (Farnan, Michael) |
| Dec 3, 2020 | 1 | Complaint* (1) |
| Dec 3, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (apk) |
| Dec 3, 2020 | 1 | Complaint (Main Document) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 1) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 2) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 3) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 4) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 5) (26) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 6) (6) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 7) (17) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 8) (7) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 9) (17) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 10) (9) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 11) (7) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 12) (6) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 13) (8) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 14) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 15) (9) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 16) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 17) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 18) (7) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 19) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 20) (9) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 21) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 22) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 23) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 24) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 25) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 26) (10) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 27) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 28) (6) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 29) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 30) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 31) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 32) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 33) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 34) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 35) (9) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 36) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 37) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 38) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 39) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 40) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 41) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 42) (15) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 43) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 44) (7) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 45) (7) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 46) (10) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 47) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 48) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 49) (13) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 50) (7) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 51) (7) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 52) (6) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 53) (6) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 54) (5) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 55) (8) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 56) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 57) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 58) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 59) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 60) (9) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 61) (3) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 62) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 63) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 64) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 65) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 66) (30) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 67) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 68) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 69) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 70) (5) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 71) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 72) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 73) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 74) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 75) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 76) (4) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 77) (6) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 78) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 79) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 80) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Exhibit 81) (2) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 1 | Complaint (Civil Cover Sheet) (1) Docket Text: COMPLAINT for Patent Infringement, with Jury Demand, against Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Filing fee $ 402, receipt number ADEDC-3372527) - filed by Ravgen, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17, # (18) Exhibit 18, # (19) Exhibit 19, # (20) Exhibit 20, # (21) Exhibit 21, # (22) Exhibit 22, # (23) Exhibit 23, # (24) Exhibit 24, # (25) Exhibit 25, # (26) Exhibit 26, # (27) Exhibit 27, # (28) Exhibit 28, # (29) Exhibit 29, # (30) Exhibit 30, # (31) Exhibit 31, # (32) Exhibit 32, # (33) Exhibit 33, # (34) Exhibit 34, # (35) Exhibit 35, # (36) Exhibit 36, # (37) Exhibit 37, # (38) Exhibit 38, # (39) Exhibit 39, # (40) Exhibit 40, # (41) Exhibit 41, # (42) Exhibit 42, # (43) Exhibit 43, # (44) Exhibit 44, # (45) Exhibit 45, # (46) Exhibit 46, # (47) Exhibit 47, # (48) Exhibit 48, # (49) Exhibit 49, # (50) Exhibit 50, # (51) Exhibit 51, # (52) Exhibit 52, # (53) Exhibit 53, # (54) Exhibit 54, # (55) Exhibit 55, # (56) Exhibit 56, # (57) Exhibit 57, # (58) Exhibit 58, # (59) Exhibit 59, # (60) Exhibit 60, # (61) Exhibit 61, # (62) Exhibit 62, # (63) Exhibit 63, # (64) Exhibit 64, # (65) Exhibit 65, # (66) Exhibit 66, # (67) Exhibit 67, # (68) Exhibit 68, # (69) Exhibit 69, # (70) Exhibit 70, # (71) Exhibit 71, # (72) Exhibit 72, # (73) Exhibit 73, # (74) Exhibit 74, # (75) Exhibit 75, # (76) Exhibit 76, # (77) Exhibit 77, # (78) Exhibit 78, # (79) Exhibit 79, # (80) Exhibit 80, # (81) Exhibit 81, # (82) Civil Cover Sheet)(apk) Modified on 12/9/2020 (nms). |
| Dec 3, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Dec 3, 2020 | 3 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,727,720 B2 ;US 7,332,277 B2. (apk) |
